PhysiologybioRxivPreprint
The RNA modification N6-methyladenosine restrains SIRPα to license myeloid efferocytosis in atherosclerosis
Aneesh S. Kallapur, Xiang Li, Elena Rodríguez‐Sánchez…·Tamer Sallam
This study identifies the m6A-SIRP axis as a regulator of efferocytosis in atherosclerosis, showing myeloid m6A loss increases plaque instability.
DOI 10.64898/2026.09.19.749544